Interestingly, in recent studies, fecal microbiota transplants helped overcome PD-1 therapy resistance in melanoma patients [41, 42] where introducing infectious agents improved ICI treatment efficacy, suggesting the infectious agents’ influence on the ICI related immune activation. The gene discussed is PDCD1; the disease is melanoma.